Cytokinetics, Incorporated CYTK
62.84 USD -0.15 -0.24%
As of Nov 2, 11:47 AM ET
58.05 52-week range 88.31
- YTD
- -1.10%
- 1 year
- -1.18%
- Open
- 63.40
- Prev close
- 62.99
- Mkt cap
- 8.74B
- Vol
- 456.85K
- Avg vol
- 1.91M
- EPS
- -7.22
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 62.23
- High
- 64.00
- Forward P/E
- -14.30
- Beta
- 0.41
- Short ratio
- 8.18
- Inst. own
- 126.00%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 4, 2026
- 50-d avg
- 67.78
- 200-d avg
- 70.09
- 1y target
- 107.26
MAX chart
Chart tools
Chart is warming up
The all-time price history for CYTK has not been loaded yet. Try again in a moment.
Altman Z-Score
-1.09 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 1
- Return on Equity 5
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
P/E -9.7×
P/S 86.6×
P/B -11.6×
P/FCF -14.3×
EV/EBITDA -11.3×
EV/Sales 99.8×
FCF Yield -7.0%
Gross Margin 88.5%
Operating Margin -695.4%
Net Margin -891.6%
ROE 119.0%
ROIC -47.7%
ROA -55.1%
Revenue 376.6%
Operating Income -14.2%
EPS (diluted) -24.3%
Free Cash Flow -33.8%
Current Ratio 4.5×
Quick Ratio 4.5×
Debt / Equity -1.9×
Net Debt / EBITDA -1.5×
Interest Coverage -5.9×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-12-31